In fact, data from the SURPASS programme, which evaluated tirzepatide in patients with type 2 diabetes, demonstrated that the medication generally has neutral-to-beneficial effects on lipid profiles, with individual responses varying
The mice maintained function longer, suggesting "compression of morbidity," the concept of staying healthy longer and experiencing decline only at the very end of life
Show Highlights & Big Takeaways Retatrutide is More Powerful, But Not Dramatically (Yet): While it works on three pathways and may lead to greater weight loss, current data shows only about a 23% improvement over Ozempic, not the massive difference often advertised
A: Semaglutide (Ozempic/Wegovy) targets only GLP-1 receptors
However, based on what we have learned from similar peptides, it could increase the risk of pancreatitis and gallbladder disease